rituximab,ibrutinib,Bendamustine
biogen,roche,novartis,janssen,abbvie
['import', 'shine']
time to shine. presenting important ph3 results in frontline mcl at #asco22. 
Hematologist @MayoClinic. Specializing in Lymphoma, CLL and Cell therapy.